Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction

Description

The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.

Conditions

Anterior Cruciate Ligament Tear, Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.

Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction: a Randomized Control Trial

Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction

Condition
Anterior Cruciate Ligament Tear
Intervention / Treatment

-

Contacts and Locations

Houston

Houston Methodist Research Institute, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients of the IRB approved surgeon(s) undergoing ACL reconstruction with bone-to-bone (BTB) autograft
  • * Patients aged between 18-40 years old at the time of surgery
  • * Patients undergoing ACL reconstruction with any other type of autograft or allograft other than BTB
  • * Patients younger than 18 years old or older than 40 years old
  • * Patients undergoing meniscal root repair or any other repair that changes their weight-bearing status
  • * Patients with a history of substance abuse
  • * Vulnerable populations
  • * Patients on chronic pain medication within the last 6 months
  • * BMI \>/= 35
  • * Allergy to morphine
  • * Unwilling to participate
  • * Any additional reason the PI deems reasonable

Ages Eligible for Study

18 Years to 40 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Methodist Hospital Research Institute,

Robert Jack, MD, PRINCIPAL_INVESTIGATOR, The Methodist Hospital Research Institute

Study Record Dates

2029-07-31